Treatment of Sleep Disorders in Children with Atopic Dermatitis: What's New?
Abstract
Atopic dermatitis (AD), also known as atopic eczema, is a chronic and inflammatory disease caused by an interaction of genetic, immunological, and environmental factors. It is characterized by skin lesions and itching and progresses with periods of improvement and worsening.
Patients with AD often experience sleep disorders, which leads to a worsening of the quality of life of patients and their families and may be associated with poorer school performance, behavioral and mood dysfunction, risk of short stature, metabolic syndrome, mental illness, neurocognitive dysfunction, psychiatric comorbidities such as anxiety, stress, depression, attention deficit hyperactivity disorder (ADHD). Furthermore, sleep disturbances in children with AD have been associated with pruritus and greater severity of dermatitis.
To this day, we do not have a curative treatment for this disease, but there is treatment, and it is possible to keep the disease under control. In these patients, controlling the condition is very important to improve the quality of sleep, at the same time, with better sleep there is greater control of AD.
Despite being very common in AD, we currently have few studies on sleep disorders and their treatment in this disease, and there is no consensus on the therapeutic approach. We carried out a descriptive study with a narrative review of the literature.
The research was based on studies published in English and Portuguese between January 2013 and October 2023,…
Read the paper
Related studies
- Tryptophan Metabolism and Gut-Brain Homeostasis
- Rationale for a Multi-Factorial Approach for the Reversal of Cognitive Decline in Alzheimer’s Disease and MCI: A Review
- Prioritized Research for the Prevention, Treatment, and Reversal of Chronic Disease: Recommendations From the Lifestyle Medicine Research Summit
- Relationship between sleep disorders and gut dysbiosis: what affects what?
- The role of CLOCK gene in psychiatric disorders: Evidence from human and animal research
- Genetic, Transcriptome, Proteomic, and Epidemiological Evidence for Blood-Brain Barrier Disruption and Polymicrobial Brain Invasion as Determinant Factors in Alzheimer’s Disease
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.